Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
What is JSP Pharmaceutical Manufacturing (Thailand) PCL PB Ratio?
JSP Pharmaceutical Manufacturing (Thailand) PCLBKK:JSP 80 PB Ratio is 0.93 as of Jul. 16, 2026, which is 22% below its 10-year median of 1.19. GuruFocus rates BKK:JSP with a GF Score™ of 80/100 and a GF Value™ of ฿3.16 (Significantly Undervalued). The stock has 5 warning signs investors should review. Among 1,900 Consumer Packaged Goods companies, JSP Pharmaceutical Manufacturing (Thailand) PCL ranks better than 66.37% on this metric.
BKK:JSP's PB Ratio is ranked better than 66.37% of 1900
companies
in the Consumer Packaged Goods industry
Industry Median: 1.36
vs BKK:JSP: 0.93
During the past 12 months, JSP Pharmaceutical Manufacturing (Thailand) PCL's average Book Value Per Share Growth Rate was 4.70% per year.
During the past 3 years, the average Book Value Per Share Growth Rate was -6.00% per year.
During the past 5 years, the average Book Value Per Share Growth Rate was 21.30% per year.
During the past 7 years, the highest 3-Year average Book Value Per Share Growth Rate of JSP Pharmaceutical Manufacturing (Thailand) PCL was 85.40% per year. The lowest was -6.00% per year. And the median was 28.40% per year.
Back to Basics: PB Ratio
JSP Pharmaceutical Manufacturing (Thailand) PCL (BKK:JSP) PB Ratio Explanation
The PB Ratio works the best for the businesses that earn most of their profit from their assets, e.g. banks and insurance companies.
Be Aware
Some businesses have very light assets, such as software companies or insurance agencies. The PB Ratio does not work well for these companies. Some companies even have negative equity, so the PB Ratio cannot be applied to them.
JSP Pharmaceutical Manufacturing (Thailand) PCL PB Ratio Related Terms
JSP Pharmaceutical Manufacturing (Thailand) PCL PB Ratio Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
JSP Pharmaceutical Manufacturing (Thailand) PCL PB Ratio Chart
JSP Pharmaceutical Manufacturing (Thailand) PCL Annual Data
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
JSP Pharmaceutical Manufacturing (Thailand) PCL PB Ratio vs Consumer Packaged Goods Industry
JSP Pharmaceutical Manufacturing (Thailand) PCL PB Ratio Calculation
The PB Ratio, or Price-to-Book ratio, or Price/Book, is a financial ratio used to compare a company's market price to its Book Value per Share. It is a ratio widely used to value stocks.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
It can also be calculated from the numbers for the whole company:
A closely related ratio is called Price-to-Tangible-Book. The difference between Price-to-Tangible-Book and PB Ratio is that book value other than intangibles are used in the calculation.
JSP Pharmaceutical Manufacturing (Thailand) PCL (BKK:JSP) has a PB Ratio of 0.93 as of Jul. 16, 2026. Price-to-Book ratio is the ratio of share price to a company's book value per share. View historical data on JSP Pharmaceutical Manufacturing (Thailand) PCL and its competitors. This is 22% below median its historical median of 1.19. Over the past decade, JSP Pharmaceutical Manufacturing (Thailand) PCL's PB Ratio has ranged from 0.85 to 17.26. According to the industry distribution chart, JSP Pharmaceutical Manufacturing (Thailand) PCL ranks #639 out of 1900 companies in the Consumer Packaged Goods industry, placing it in the top 33.6%.
Is JSP Pharmaceutical Manufacturing (Thailand) PCL's PB Ratio too high?
JSP Pharmaceutical Manufacturing (Thailand) PCL's current PB Ratio of 0.93 is 22% below median its 10-year median of 1.19. Over the past 10 years, this metric has ranged from a low of 0.85 to a high of 17.26. The Consumer Packaged Goods industry median PB Ratio is 1.36. JSP Pharmaceutical Manufacturing (Thailand) PCL's value of 0.93 is 31.6% below this industry median. Based on the distribution chart, JSP Pharmaceutical Manufacturing (Thailand) PCL ranks #639 out of 1900 companies in the Consumer Packaged Goods industry, which is above the industry midpoint. Overall, JSP Pharmaceutical Manufacturing (Thailand) PCL has a GF Score™ of 80/100 and is considered Significantly Undervalued, reflecting its overall financial health beyond just this single metric.
How does JSP Pharmaceutical Manufacturing (Thailand) PCL's PB Ratio compare to KHC and GIS?
According to the Consumer Packaged Goods industry distribution chart, JSP Pharmaceutical Manufacturing (Thailand) PCL ranks #639 out of 1900 companies for PB Ratio. This puts JSP Pharmaceutical Manufacturing (Thailand) PCL in the upper half of its industry. The industry median PB Ratio is 1.36. JSP Pharmaceutical Manufacturing (Thailand) PCL's value of 0.93 is 31.6% below this benchmark. Historically, JSP Pharmaceutical Manufacturing (Thailand) PCL's own PB Ratio has ranged from 0.85 to 17.26 over the past decade. While the company's 10-year median is 1.19 vs. the industry median of 1.36, JSP Pharmaceutical Manufacturing (Thailand) PCL has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good PB Ratio for a Consumer Packaged Goods company?
The median PB Ratio among Consumer Packaged Goods companies is 1.36, based on 1,900 companies in the industry. Companies in the top quartile (top 25%) have a PB Ratio significantly above this median, while those in the bottom quartile fall well below. However, PB Ratio should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. JSP Pharmaceutical Manufacturing (Thailand) PCL's current PB Ratio of 0.93 is 31.6% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high PB Ratio mean?
A high PB Ratio can signal that a stock is expensive relative to its fundamentals. Price-to-Book ratio is the ratio of share price to a company's book value per share. View historical data on JSP Pharmaceutical Manufacturing (Thailand) PCL and its competitors. For the Consumer Packaged Goods industry, the median PB Ratio is 1.36 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. JSP Pharmaceutical Manufacturing (Thailand) PCL's current PB Ratio is 0.93, which is 22% below median its own 10-year median of 1.19. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is JSP Pharmaceutical Manufacturing (Thailand) PCL stock overvalued right now?
Based on GuruFocus' analysis, JSP Pharmaceutical Manufacturing (Thailand) PCL (BKK:JSP) is currently considered Significantly Undervalued. The stock's GF Value™ is ฿3.16, compared to a current price of ฿1.78 — trading 43.7% below its estimated fair value. The current PB Ratio is 0.93, which is 22% below median its 10-year median of 1.19 and 31.6% below the Consumer Packaged Goods industry median of 1.36. JSP Pharmaceutical Manufacturing (Thailand) PCL's overall GF Score™ is 80/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is PB Ratio calculated?
PB Ratio is calculated from a company's financial statements. For JSP Pharmaceutical Manufacturing (Thailand) PCL (BKK:JSP), the current PB Ratio is 0.93 as of Jul. 16, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is JSP Pharmaceutical Manufacturing (Thailand) PCL (BKK:JSP) Overvalued in 2026?
Based on GuruFocus' analysis, JSP Pharmaceutical Manufacturing (Thailand) PCL stock appears to be undervalued.
The current stock price of ฿1.78 is trading 43.7% below its estimated GF Value™ of ฿3.16.
GuruFocus considers JSP Pharmaceutical Manufacturing (Thailand) PCL to be Significantly Undervalued.
Key valuation signals for BKK:JSP:
PB Ratio: 0.93 (22% below median its 10-year median of 1.19)
GF Value™: ฿3.16 vs. price of ฿1.78 (43.7% below fair value)
Industry Position: 31.6% below the Consumer Packaged Goods median (#639 of 1900)
No single metric tells the full story. See the BKK:JSP stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
JSP Pharmaceutical Manufacturing (Thailand) PCL Business Description
JSP Pharmaceutical Manufacturing (Thailand) PCL is engaged in producing modern medicine, traditional medicine, herbal products, dietary supplements, medical supplies, and cleaning alcohol under the client's and the company's own trademarks. Maximum revenue for the company is generated from the sale of dietary supplements. The Group's reportable operating segments are: Manufacture and distribution of products under the company's brand name (Own brands), which generate maximum revenue, Manufacture and distribution of products under customers' brand name (OEM), Manufacture and distribution of hemodialysis solution and related medical supplies; and Service, research and development, and healthcare products training. Geographically, it operates principally in Thailand.
80GF Score
Get the complete analysis for BKK:JSP
PB Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
BKK:JSP has been successfully added to your 
